Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Andrey Manov"'
Autor:
Ikechukwu R Ogbu, Chinedu Ngwudike, Kingsley Dah, Andrey Manov, Alfred Danielian, Shadi N Daoud
Publikováno v:
World Journal of Advanced Research and Reviews. 13:599-613
The ethnic differences in cardiovascular outcomes with sodium-glucose cotransporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1 (GLP-1) receptor agonists in patients with type 2 diabetes and heart failure are not well established. We conducted
We are describing a patient with malignant insulinoma and unusual clinical and pathological features. The patient presented late in the course of the disease with history of abdominal pain and was found to have large tumor of the pancreas and metasta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1f992f5f5c19aeacdb278d1ff2bd722
Publikováno v:
Medical and Clinical Research: Open Access. 1
Clinical Vignette A 45 year old Caucasian man presented to the emergency department with worsening left leg swelling and pain since four days prior to visit. Symptoms were progressively worse over the last 4- days and associated with moderate to seve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2659::b47c31ff88b636ff8be389458c6ec93a
https://zenodo.org/record/7932038
https://zenodo.org/record/7932038
Autor:
Andrey Manov
Publikováno v:
Open Access Journal of Endocrinology. 4
We have described a 44-year old man with past medical history of resistant hypertension on 4-antihypertensive medications including diuretic. He has not been investigated for secondary causes of hypertension despite having elevated blood pressure for
Autor:
Andrey Manov
Publikováno v:
Annals of Bioethics & Clinical Applications. 3
Autor:
Andrey Manov
Publikováno v:
Annals of Bioethics & Clinical Applications. 3
Publikováno v:
Journal of Clinical Medical Research.
Autor:
Andrey Manov
Publikováno v:
Open Access Journal of Endocrinology. 4
Testosterone replacement therapy is the mainstay treatment for both primary and secondary hypogonadism. Clinical benefits of testosterone include improvement of the muscle mass, libido, and bone density. However, there are potential risks associated
Publikováno v:
Clinical Research and Trials. 2